Hiroki Nakano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroki Nakano has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Sho Yonezawa
RWD Analytics, Healthcare & Life Science, IBM Japan Ltd., Tokyo, Japan
2 shared publications - Yoshinori Kabeya
RWD Analytics, Healthcare & Life Science, IBM Japan Ltd., Tokyo, Japan
2 shared publications - Ami Kamada
RWD Analytics, Healthcare & Life Science, IBM Japan Ltd., Tokyo, Japan
1 shared publication - Atsushi Takano
IBM Japan Ltd.
1 shared publication - Chiaki Morita
Tokyo Laboratory, IBM Japan Ltd
1 shared publication - Eisuke Murakami
Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
1 shared publication
Latest Publications
- Open Access
- 20 May 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (3) , 976-989
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease
Background and Aims: Identifying patients with steatotic liver disease who are at a high risk of developing HCC remains challenging. We present a deep learning (DL) model to predict HCC development using hematoxylin and eosin-stained whole-slide images of biopsy-proven steatotic liver disease. Approach and Results: We included 639 patients who did not develop HCC for ≥7 years after biopsy (non-HCC class) and 46 patients who developed HCC Export
- 20 May 2024
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (3) , 976-989
Open AccessDeep learning and digital pathology powers prediction of HCC development in steatotic liver disease
Background and Aims: Identifying patients with steatotic liver disease who are at a high risk of developing HCC remains challenging. We present a deep learning (DL) model to predict HCC development using hematoxylin and eosin-stained whole-slide images of biopsy-proven steatotic liver disease. Approach and Results: We included 639 patients who did not develop HCC for ≥7 years after biopsy (non-HCC class) and 46 patients who developed HCC Export
- Open Access
A deep convolutional neural network-based algorithm for muscle biopsy diagnosis outperforms human specialists
Histopathologic evaluation is essential for categorizing and studying neuromuscular disorders. However, experienced specialists and pathologists are limited, especially in underserved areas. Although new technologies, such as artificial intelligence, are expected to improve medical reach, their use in rare diseases is challenging because of the limited availability of training datasets. To address this knowledge gap, we developed an algorithm based on deep convolutional neural networks that used data from microscopic images of hematoxylin-and-eosin-stained pathology slides. Our algorithm differentiated idiopathic inflammatory myopathies (mostly treatable) from hereditary muscle diseases (mostly non-treatable) and achieved better sensitivity and specificity than real physicians' diagnoses. Furthermore, it successfully and accurately classified four subtypes of the abovementioned muscular conditions. These results suggest that our algorithm can be safely used in a clinical setting. We established the similarity between the algorithm's and physicians' predictions using visualization technology, and clarified the validity of the predictions.
Open AccessA deep convolutional neural network-based algorithm for muscle biopsy diagnosis outperforms human specialists
Histopathologic evaluation is essential for categorizing and studying neuromuscular disorders. However, experienced specialists and pathologists are limited, especially in underserved areas. Although new technologies, such as artificial intelligence, are expected to improve medical reach, their use in rare diseases is challenging because of the limited availability of training datasets. To address this knowledge gap, we developed an algorithm based on deep convolutional neural networks that used data from microscopic images of hematoxylin-and-eosin-stained pathology slides. Our algorithm differentiated idiopathic inflammatory myopathies (mostly treatable) from hereditary muscle diseases (mostly non-treatable) and achieved better sensitivity and specificity than real physicians' diagnoses. Furthermore, it successfully and accurately classified four subtypes of the abovementioned muscular conditions. These results suggest that our algorithm can be safely used in a clinical setting. We established the similarity between the algorithm's and physicians' predictions using visualization technology, and clarified the validity of the predictions.
- 21 August 2015
- Published by Springer Nature
- p. 36-45
Large Scale Specific Object Recognition by Using GIFTS Image Feature
- 21 August 2015
- Published by Springer Nature
- p. 36-45
Large Scale Specific Object Recognition by Using GIFTS Image Feature